Constructing the Future of Health

Stanford’s Division of Computational Medicine

December 9, 2025 by Rebecca Handler

For nearly forty years, Stanford’s Division of Biomedical Informatics Research (BMIR) has quietly shaped the way medicine understands data. Its faculty have built the frameworks that let clinicians ask sharper questions, the algorithms that make sense of millions of medical records, and the systems that help translate discovery into practice.

(Left): Manisha Desai, PhD (Right): Mark Musen, MD

But as their work has expanded — from building databases to designing AI models that guide clinical care, the name Biomedical Informatics Research no longer feels large enough to hold it.

That evolution has now been captured in a new name: Computational Medicine, with a mission embodied in its tagline: Constructing the Future of Health with Data-Driven Tools.

“The change reflects the department’s evolution toward a deeper integration with clinical science and the generation of rigorous, reproducible evidence to improve health,” said Manisha Desai, PhD, Professor of Medicine and Section Chief of Biostatistics.

“As a division in the Department of Medicine, we have always had a tight connection with the clinical enterprise and with laboratory research,” added Mark Musen, MD, Professor of Biomedical Informatics Research, and the division’s director. “The new name emphasizes that relationship much better, and it helps people to understand that our work is driven by a desire to create tangible outcomes throughout the medical center.”

Why the Name Matters

Nigam Shah, MBBS, PhD

“The ultimate goal of all we do is to improve medical care, and we use computation heavily in our work,” said Nigam Shah, MBBS, PhD, the division’s Associate Director, and Chief Data Scientist at Stanford Healthcare. “Computational Medicine is a more direct way to convey what we do.”

Juliet Lee

Juliet Lee, the division’s Administrative Director, described the shift as a natural next step. “It represents the evolution of our work and the increasing role of computation in shaping modern medicine,” she said. “It better reflects our mission to harness data science and AI to drive innovations in human health.”

Jonathan Chen, MD, PhD

For Jonathan Chen, MD, PhD, Stanford’s Director for Medical Education in Artificial Intelligence, the change is also about accessibility. “Many people simply don’t know what informatics means,” he noted. “Computation is universal. The new name helps people instantly understand that our expertise lies in using data and technology to solve medical problems.”


Defining the Mission Behind the Tagline

The new tagline, Constructing the Future of Health with Data-Driven Tools, captures both the precision of the field and the pragmatism of its faculty.

“It directly defines our mission: to build tools on data, to improve health,” said Shah.
“It conveys our commitment to translating data into tangible solutions that advance care,” added Lee.

Desai explained that the shift also repositions the division squarely within medicine. “While biomedical informatics traditionally emphasized data systems and information management,” she said, “computational medicine underscores the use of quantitative science — biostatistics, computation, and modeling — as drivers of clinical discovery and decision-making.”

Purvesh Khatri, PhD

Purvesh Khatri, PhD, Professor of Medicine in Biomedical Informatics at the Research Institute for Immunity, Transplantation and Infection, agreed. “Biomedical informatics tends to stop short of clinical translation,” he said. “Computational medicine implies the full continuum, from data to practice to delivery.”

“Our division has been remarkably successful in developing technology that is used widely in the clinical arena and in the laboratory,” Musen added. “Our faculty members can point to many thousands of users for their contributions, and it’s a distinguishing feature of our group.”

Translational Impact

Inside the division, that continuum is already taking shape.

A major goal for Desai’s team is to design studies with clinical investigators that will be impactful and informative. To that end, the team is building StatChat, a suite of tools designed by statisticians and for statisticians to make rigorous, ethical statistical practice more efficient. Her group has also developed novel frameworks for evaluating AI-supported interventions, redefining what a clinical trial can look like. “Our approach has transformed how trials are performed,” she said. “A diabetes management program we evaluated in this framework is now part of Stanford’s healthcare system and continually refined in real time.”

Shah’s data science team leads the development of ChatEHR, a generative AI platform that enables use of language models directly in clinical workflows. It is available to over 5000 physicians and nurses for interacting with a patient’s complete medical record, to summarize the record, draft documentation for patients or insurers, identify care gaps as well as automate rote tasks, while preserving privacy and institutional control.

Chen’s group studies how computational tools intersect with human clinical judgment. His team’s SmartAlert framework takes that insight directly to the bedside. The system continuously analyzes streams of clinical data to anticipate diagnostic or treatment needs, surfacing timely, evidence-based recommendations tailored to each patient’s situation. Already being rolled out across the hospital, SmartAlert helps clinicians act earlier and with greater precision than traditional rule-based systems could provide.

Khatri pointed to the TriVerity test as another example of clinically grounded innovation. The quick blood test turns complex lab data into three easy-to-read scores that help doctors decide, in real time, whether a patient has an infection, how severe it is, and whether they may soon need intensive care. “Because we’re embedded in medicine, we knew the real question wasn’t just ‘Does this patient have sepsis?’” Khatri said. “It was, ‘Does the patient have an infection, and how serious is it?’ That nuance guided the design.”

Musen’s group contributes foundational infrastructure that powers these innovations. “Protégé, a tool developed in our lab, is now the primary way people build controlled vocabularies in biomedicine,” he said. “It’s what the National Cancer Institute uses to define cancer terms and what the World Health Organization uses to build the latest global disease classification system.”

Collaboration as Core Infrastructure

The new identity also reflects how the division works. “Modern biomedical problems are too complex for any single discipline,” said Desai. “The success of our projects rely on multiple perspectives – e.g., oncologists, pathologists, biostatisticians, and computational biologists on one team with shared goals. These collaborations expose new methodological gaps that push the science forward.

For Shah, location matters. “Roughly seventy percent of patients seen at Stanford Health Care are cared for by our department’s faculty,” he said. “That gives us a direct bridge between data science and clinical practice.”

As Chen puts it, “Innovation happens at the interfaces — but only when people truly understand both sides.”

Musen emphasized the same point: “Virtually everything we do is interdisciplinary. All of our projects involve team science, and our position in the Department of Medicine gives us ready access to clinicians and bench scientists eager to collaborate.”


Looking Ahead

When asked what the “future of health” looks like, faculty members offered a piece of a shared vision:

  • Desai sees “care decisions optimized and driven by rigorous evidence.”

  • Lee imagines “data-driven decisions that are precise, equitable, and personalized.”

  • Khatri envisions “a continuous feedback loop between science, practice, and delivery.”

  • Chen foresees “the democratization of expertise: new forms of care mediated or delivered by AI systems that would once have seemed impossible.”

  • Musen shared, “Computational medicine will accelerate the ways biomedical research informs clinical decision-making. By revolutionizing how we collect, disseminate, and use experimental data, we can speed the delivery of new results into the clinical arena to improve health in concrete ways.”

 

As the division celebrates its new chapter at the December rebranding event, that vision feels within reach. “Computational Medicine is more relevant and collaborative than ever,” said Lee. “It’s both recognition and renewal.”

Khatri calls it “a testament to the division’s adaptability and leadership in advancing science, practice, and delivery,” while Chen adds, “This rebrand lets us finally say, in plain language, what we’ve been doing all along — building the computational foundations of modern medicine.”

About Us

Computational Medicine uses advanced research techniques to discover, apply, translate, and organize data that make a difference for health and healthcare. With its expertise in clinical and translational informatics research and biostatistics, the division works to uncover new ways to advance personalized medicine and to enhance human health and wellness.